EpistrySign in
LimitedMetadata only — full assessment not yet run

Therapeutic advances in COVID-19

Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al‐Samkari, Jonathan D. Casey, Lorenzo Del Sorbo, Patrick R. Lawler, Meghan E. Sise, David E. Leaf · Nature Reviews Nephrology · 2022

DOI 10.1038/s41581-022-00642-4

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (Nature Reviews Nephrology). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationhighly cited
    • Cited by 160 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in Nature Reviews Nephrology.
    • Publisher: Nature Portfolio.
    • ISSN 1745-8323.
    • The journal is not listed in DOAJ.
    • Open-access status: bronze.
Assessed by Epistry · metadata as of August 23, 2026
Therapeutic advances in COVID-19 — Epistry